Family study of small intestine carcinoid tumors
Treatments studied
Part of Cancer clinical trials.
This is a research study that follows families with small intestine carcinoid tumors (and related hormone-related tumors) to learn how these conditions progress over time. It may help doctors better predict risk and health needs for people in similar families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- You have small intestine carcinoid tumor OR you’re in a specific family pattern of related tumors
- At least one close blood relative has one of these tumor types (small intestine carcinoid, lung, kidney, stomach/intestine-area, or a tumor of unknown origin that acts like a neuroendocrine tumor)
- You may also qualify if you personally have multiple small intestine tumors at the same time
- This study is about certain families only—if your family has MEN1, MEN2, von Hippel-Lindau, or neurofibromatosis type 1 or 2, you likely can’t join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
This study looks at how bacteria in your gut may affect the growth of small-intestine neuroendocrine tumors. If you are having surgery to remove one of these tumors, the research team will collect samples and data to better understand the link between your gut bacteria and the tumor.
This study is a registry that collects information from people with carcinoid heart disease, a heart condition caused by neuroendocrine tumors. By gathering data on symptoms, test results, and outcomes, researchers hope to better understand and improve care for this condition.
This study looks at how tumors in the digestive system interact with the body’s immune system and the surrounding environment. Results may help improve understanding of these cancers and guide future treatments.
This study looks at how certain genetic changes in tumor tissue might help doctors monitor how well treatment is working for colorectal or small intestinal cancer. By joining, you may help researchers find better ways to track the disease and guide future treatment.
This study aims to find genetic causes of neuroendocrine tumors in Mexican patients. By understanding your DNA, researchers hope to improve diagnosis and treatment for people with these rare conditions.
Hear when a new Carcinoid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.